Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10266733 | 0.94 | USP2 (0.40) | USP2MAPTTSHRRECQLCYP1A2 | |
| SCHEMBL893126 | 0.88 | RECQL (0.36) | USP2MAPTTSHRRECQL | |
| SCHEMBL9408520 | 0.87 | RECQL (0.35) | USP2MAPTTSHRRECQLCYP1A2 | |
| SCHEMBL892909 | 0.87 | RECQL (0.35) | USP2MAPTTSHRRECQLCYP1A2 | |
| SCHEMBL6128328 | 0.79 | RECQL (0.38) | RECQL | |
| SCHEMBL5399571 | 0.78 | TSHR (0.34) | USP2MAPTTSHR | |
| SCHEMBL8674705 | 0.77 | RECQL (0.38) | RECQL | |
| SCHEMBL9408521 | 0.77 | USP2 (0.32) | USP2MAPTTSHR | |
| SCHEMBL3294145 | 0.77 | USP2 (0.32) | USP2MAPTTSHR | |
| SCHEMBL15215213 | 0.76 | RECQL (0.37) | RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9760060-B2 | Photopolymer formulations for producing holographic media having highly crosslinked matrix polymers | COVESTRO DEUTSCHLAND AG (DE) | 2017-09-12 | — | — | US | disclosed |
| US-20150353485-A1 | SECURITY ELEMENT HAVING VOLUME HOLOGRAM AND PRINTED FEATURE | COVESTRO DEUTSCHLAND AG (DE) | 2015-12-10 | — | — | US | disclosed |
| US-9146456-B2 | Photopolymer formulation for producing holographic media having highly crosslinked matrix polymers | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-09-29 | — | — | US | disclosed |
| US-20130224634-A1 | PHOTOPOLYMER FORMULATION FOR PRODUCING HOLOGRAPHIC MEDIA HAVING HIGHLY CROSSLINKED MATRIX POLYMERS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150353485-A1 | SECURITY ELEMENT HAVING VOLUME HOLOGRAM AND PRINTED FEATURE | SHH, ABL1, MKI67 | USP2 207/4885MAPT 1247/4885TSHR 4496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.